News
Esperion (NASDAQ: ESPR) today announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka), the Company’s partner for the development and commercialization of NEXLETOL ® (bempedoic acid) tablets in Japan, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback